These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31407970)

  • 21. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
    Lam AP; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Rösler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Müller HHO; Lücke C; Huss M; Jans T; Berger M; Tebartz van Elst L; Philipsen A;
    JAMA Netw Open; 2019 May; 2(5):e194980. PubMed ID: 31150084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis.
    Tamminga HG; Reneman L; Huizenga HM; Geurts HM
    Psychol Med; 2016 Jul; 46(9):1791-807. PubMed ID: 27019103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorder.
    An L; Cao XH; Cao QJ; Sun L; Yang L; Zou QH; Katya R; Zang YF; Wang YF
    Neuropsychopharmacology; 2013 Jun; 38(7):1287-95. PubMed ID: 23340519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
    Idema IME; Payne JM; Coghill D
    J Consult Clin Psychol; 2021 Jul; 89(7):615-625. PubMed ID: 34383534
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Greenhill LL; Findling RL; Swanson JM;
    Pediatrics; 2002 Mar; 109(3):E39. PubMed ID: 11875167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone.
    Spencer TJ; Bhide P; Zhu J; Faraone SV; Fitzgerald M; Yule AM; Uchida M; Spencer AE; Hall AM; Koster AJ; Feinberg L; Kassabian S; Storch B; Biederman J
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29617066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients.
    Solleveld MM; Schrantee A; Puts NAJ; Reneman L; Lucassen PJ
    Neuroimage Clin; 2017; 15():812-818. PubMed ID: 28725548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
    Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
    Wigal SB; Childress A; Berry SA; Belden H; Walters F; Chappell P; Sherman N; Orazem J; Palumbo D
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):690-699. PubMed ID: 28557548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic Brain Connectivity Following Long-Term Treatment with Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder.
    Battel L; Kieling RR; Kieling C; Anés M; Aurich NK; da Costa JC; Rohde LA; Franco AR
    J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):555-61. PubMed ID: 27027427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
    Childress AC; Kollins SH; Cutler AJ; Marraffino A; Sikes CR
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):66-74. PubMed ID: 27183299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder.
    Froehlich TE; Antonini TN; Brinkman WB; Langberg JM; Simon JO; Adams R; Fredstrom B; Narad ME; Kingery KM; Altaye M; Matheson H; Tamm L; Epstein JN
    J Dev Behav Pediatr; 2014; 35(2):100-7. PubMed ID: 24509055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
    Levin FR; Evans SM; Brooks DJ; Garawi F
    Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex-Based Dissociation of White Matter Microstructure in Children With Attention-Deficit/Hyperactivity Disorder.
    Jacobson LA; Peterson DJ; Rosch KS; Crocetti D; Mori S; Mostofsky SH
    J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):938-46. PubMed ID: 26506584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.